Multi-Risk Test (MRT)
Suite of Cancers, Coronary Artery Disease, Type 2 Diabetes
Key Facts
About GeneType
GeneType, founded in 2017 and headquartered in San Francisco, is a leader in the personalized predictive genetics space. Its core offering is the geneType platform, which combines polygenic risk scores, inherited monogenic data, and clinical risk factors into integrated risk assessments for a range of chronic diseases. The company's flagship Multi-Risk Test (MRT), launched in 2021, has demonstrated significant clinical utility, identifying a high percentage of at-risk individuals without a family history. GeneType operates a B2B2C model, distributing its tests exclusively through medical practitioners, and is backed by over 20 years of scientific research, numerous patents, and peer-reviewed publications.
View full company profile